179 related articles for article (PubMed ID: 28295713)
1. CD8
Jee YK; Kim S; Lee JM; Park HS; Kim SH
Clin Exp Allergy; 2017 Jul; 47(7):972-974. PubMed ID: 28295713
[No Abstract] [Full Text] [Related]
2. Cross-Reactivity Between Carbonic Anhydrase Inhibitor Confirmed by Lymphocyte Transformation Test: A Case of Methazolamide-Induced Toxic Epidermal Necrolysis.
Sohn KH; Kim SH; Kang HR
J Investig Allergol Clin Immunol; 2021 Oct; 31(5):455-456. PubMed ID: 33439124
[No Abstract] [Full Text] [Related]
3. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Kim SH; Kim M; Lee KW; Kim SH; Kang HR; Park HW; Jee YK
Pharmacogenomics; 2010 Jun; 11(6):879-84. PubMed ID: 20504258
[TBL] [Abstract][Full Text] [Related]
4. Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
Tangamornsuksan W; Lohitnavy M
Pharmacogenomics J; 2019 Jun; 19(3):286-294. PubMed ID: 30242287
[TBL] [Abstract][Full Text] [Related]
5. Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901.
Xu Y; Wu M; Sheng F; Sun Q
Indian J Ophthalmol; 2015 Jul; 63(7):623-4. PubMed ID: 26458485
[No Abstract] [Full Text] [Related]
6. Toxic epidermal necrolysis induced by methazolamide in a Chinese-Korean man carrying HLA-B*59:01.
Shu C; Shu D; Tie D; Yu M; Zhang R; Wang T; Dong Q; Sun Q; Mao X; Yan Y
Int J Dermatol; 2015 Nov; 54(11):1242-5. PubMed ID: 25970075
[TBL] [Abstract][Full Text] [Related]
7. A rare case of topical methazolamide ophthalmic solution causing death due to toxic epidermal necrolysis.
Shi L; Li M; Zhang F; Wang B; Yi X; Ding Y; Wang X
Clin Exp Dermatol; 2018 Apr; 43(3):326-327. PubMed ID: 29330876
[No Abstract] [Full Text] [Related]
8. Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement.
Kim S; Yun J; Kang DY; Park HJ; Jo EJ; Jung JW; Park HK; Park JW; Jee YK; Kang HR; Lee JM
J Allergy Clin Immunol Pract; 2019; 7(8):2851-2853.e2. PubMed ID: 31128378
[No Abstract] [Full Text] [Related]
9. Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid.
Jiang YY; Nguyen GH; Jin HZ; Zeng YP
Int J Dermatol; 2018 Apr; 57(4):494-496. PubMed ID: 29359334
[No Abstract] [Full Text] [Related]
10. In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
Porebski G; Pecaric-Petkovic T; Groux-Keller M; Bosak M; Kawabata TT; Pichler WJ
Clin Exp Allergy; 2013 Sep; 43(9):1027-37. PubMed ID: 23957338
[TBL] [Abstract][Full Text] [Related]
11. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome induced by methazolamide treatment.
Shirato S; Kagaya F; Suzuki Y; Joukou S
Arch Ophthalmol; 1997 Apr; 115(4):550-3. PubMed ID: 9109770
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-C*01:02 with methazolamide-induced toxic epidermal necrolysis.
Qiumei G; Zhengju C; Xuefei H; Qu C
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36572447
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
Xiong H; Wang L; Jiang M; Chen S; Yang F; Zhu H; Zhu Q; Tang C; Qin S; Xing Q; Luo X
Mol Immunol; 2019 Feb; 106():170-177. PubMed ID: 30623817
[TBL] [Abstract][Full Text] [Related]
15. Genetic markers for methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Huang PW; Chu CY
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):764. PubMed ID: 35536169
[No Abstract] [Full Text] [Related]
16. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
Watanabe H; Iijima M
Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
[No Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
Gerull R; Nelle M; Schaible T
Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women.
Flach AJ; Smith RE; Fraunfelder FT
Ophthalmology; 1995 Nov; 102(11):1677-80. PubMed ID: 9098261
[TBL] [Abstract][Full Text] [Related]
19. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
20. The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells.
Sasabe T; Maeda S; Kishida K; Yamano M; Miwa Y; Sugiyama T
Drug Metab Lett; 2017; 10(4):295-305. PubMed ID: 28137210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
